Clinical Trial Update: PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery [NA]

View source ↗

Summary

Clinical trial update for the PAVE System to treat chronic visual field loss due to stroke, traumatic brain injury, or brain surgery. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homonymous Hemianopsia
• Homonymous Quadrantanopia

Drugs mentioned

• PAVE System

Snippet

Sponsor: NeuroAEye LLC | Conditions: Homonymous Hemianopsia, Homonymous Quadrantanopia | NA | Status: RECRUITING